[HTML][HTML] Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice
K Tsuchida - Acta Myologica, 2008 - ncbi.nlm.nih.gov
Gene-targeted therapies, such as adeno-associated viral vector (AAV)-mediated gene
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice
K Tsuchida - Acta Myologica, 2008 - pure.fujita-hu.ac.jp
Gene-targeted therapies, such as adeno-associated viral vector (AAV)-mediated gene
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice
K Tsuchida - … and cardiomyopathies: official journal of the …, 2008 - pubmed.ncbi.nlm.nih.gov
Gene-targeted therapies, such as adeno-associated viral vector (AAV)-mediated gene
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
[引用][C] MYOSTATIN INHIBITION BY A FOLLISTATIN-DERIVED PEPTIDE AMELIORATES THE PATHOPHYSIOLOGY OF MUSCULAR DYSTROPHY MODEL MICE
K TSUCHIDA - 2008 - sid.ir
[PDF][PDF] Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice
K TSUCHIDA - Acta Myologica, 2008 - researchgate.net
Gene-targeted therapies, such as adeno-associated viral vector (AAV)-mediated gene
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
K Tsuchida - … : Myopathies and Cardiomyopathies: Official Journal of …, 2008 - europepmc.org
Gene-targeted therapies, such as adeno-associated viral vector (AAV)-mediated gene
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice
K Tsuchida - Acta Myologica, 2008 - pure.fujita-hu.ac.jp
抄録 Gene-targeted therapies, such as adeno-associated viral vector (AAV)-mediated gene
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
[引用][C] MYOSTATIN INHIBITION BY A FOLLISTATIN-DERIVED PEPTIDE AMELIORATES THE PATHOPHYSIOLOGY OF MUSCULAR DYSTROPHY MODEL MICE
K TSUCHIDA - 2008 - sid.ir
Myostatin inhibition by a follistatin-derived peptide ameliorates the pathophysiology of muscular dystrophy model mice.
K Tsuchida - … : Myopathies and Cardiomyopathies: Official Journal of …, 2008 - europepmc.org
Gene-targeted therapies, such as adeno-associated viral vector (AAV)-mediated gene
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …
therapy and cell-mediated therapy using myogenic stem cells, are hopeful molecular …